| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US6291488 | GLAXOSMITHKLINE | Preventing protozoal infections |
Nov, 2013
(10 years ago) | |
| US5998449 | GLAXOSMITHKLINE | Combination of atovaquone with proguanil for the treatment of protozoal infections |
Nov, 2013
(10 years ago) | |
| US6166046 | GLAXOSMITHKLINE | Combination of atovaquone with proguanil for the treatment of protozoal infections |
Nov, 2013
(10 years ago) | |
|
US6291488 (Pediatric) | GLAXOSMITHKLINE | Preventing protozoal infections |
May, 2014
(9 years ago) | |
|
US5998449 (Pediatric) | GLAXOSMITHKLINE | Combination of atovaquone with proguanil for the treatment of protozoal infections |
May, 2014
(9 years ago) | |
|
US6166046 (Pediatric) | GLAXOSMITHKLINE | Combination of atovaquone with proguanil for the treatment of protozoal infections |
May, 2014
(9 years ago) | |
Malarone is owned by Glaxosmithkline.
Malarone contains Atovaquone; Proguanil Hydrochloride.
Malarone has a total of 6 drug patents out of which 6 drug patents have expired.
Expired drug patents of Malarone are:
- US6291488
- US5998449
- US6166046
- US6291488*PED
- US5998449*PED
- US6166046*PED
Malarone was authorised for market use on 14 July, 2000.
Malarone is available in tablet;oral dosage forms.
Malarone can be used as method of use of atovaquone and proguanil, treatment of protozoal infection.
The generics of Malarone are possible to be released after 25 May, 2014.
Drugs and Companies using ATOVAQUONE; PROGUANIL HYDROCHLORIDE ingredient
Market Authorisation Date: 14 July, 2000
Treatment: Method of use of atovaquone and proguanil; Treatment of protozoal infection
Dosage: TABLET;ORAL
MALARONE family patents
